BioLineRX

BLRX

Capitalización de mercado USD 6.47 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Senvest Management New York	USD 2.84 M	–	–	–
2	2 OrbiMed New York	USD 831 k	–	–	–
3	3 Alyeska Investment Group Chicago, Illinois	USD 490 k	+USD 11.8 k	+21	+2%
4	4 Morgan Stanley New York	USD 387 k	+USD 48.1 k	+86	+12%
5	5 Millennium Management New York	USD 340 k	-USD 69.9 k	-125	-15%
6	OM 6 Opaleye Management Boston, Massachusetts	USD 223 k	–	–	–
7	7 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 194 k	–	–	–
8	8 Menta Capital San Francisco, California	USD 79 k	-USD 560	-1	-0.6%
9	BCA 9 Benchmark Capital Advisors New York	USD 35 k	-USD 2.8 k	-5	-6%
10	10 Ladenburg Thalmann Financial Services Miami, Florida	USD 32 k	–	–	–
11	11 Next Financial Group Houston, Texas	USD 31 k	–	–	–
12	12 UBS Group Zurich, Switzerland	USD 29 k	+USD 31.9 k	+57	+1,900%
13	13 Virtu KCG Holdings New York	USD 24 k	-USD 99 k	-177	-78%
14	14 Cutter & Co Brokerage Ballwin, Missouri	USD 20 k	+USD 23.5 k	+42	Nuevas
15	ARTA 15 A.R.T. Advisors New York	USD 20 k	+USD 24.1 k	+43	Nuevas
16	16 Commonwealth Equity Services Waltham, Massachusetts	USD 18 k	–	–	–
17	17 Two Sigma Securities New York	USD 14 k	-USD 2.24 k	-4	-12%
18	18 Bank of New York Mellon New York	USD 14 k	–	–	–
19	19 Bank of America Charlotte, North Carolina	USD 13 k	–	–	–
20	20 Creative Planning Overland Park, Kansas	USD 12 k	–	–	–
21	21 Royal Bank of Canada Toronto, Ontario, Canada	USD 4 k	–	–	–
22	22 Krilogy Financial St. Louis, Missouri	USD 1 k	–	–	–
23	23 Wealthcare Capital Management Richmond, Virginia	USD 1 k	–	–	–
24	24 Wells Fargo San Francisco, California	USD 1 k	–	–	–
25	25 Susquehanna International Group Bala Cynwyd, Pennsylvania	–	-USD 40 k	-65	Cerradas

BioLineRX BLRX Capitalización de mercado USD 6.47 M

BioLineRX

BLRX

Capitalización de mercado USD 6.47 M